From: Distinct phenotypes of multisystem inflammatory syndrome in children: a cohort study
MIS-C features | Wave 1 vs. 2 | Wave 1 vs. 3 | Wave 1 vs. 4 | Wave 2 vs. 3 | Wave 2 vs. 4 | Wave 3 vs. 4 |
---|---|---|---|---|---|---|
Shock/hypotension | 0.03 | 0.13 | 0.28 | 0.56 | 0.43 | > 0.99 |
Skin rash | > 0.99 | 0.28 | 0.08 | 0.14 | 0.008 | 0.36 |
Peak ferritin | 0.83 | 0.04 | 0.01 | 0.02 | 0.02 | 0.55 |
Liver enzyme abnormalities | 0.67 | 0.39 | 0.32 | 0.06 | 0.05 | > 0.99 |
Peak D-dimer | 0.63 | 0.08 | 0.07 | 0.05 | 0.02 | 0.55 |
Peak troponin | 0.002 | 0.02 | 0.002 | 0.66 | 0.2 | 0.14 |
Thrombocytopenia | 0.37 | 0.07 | 0.01 | 0.21 | 0.04 | 0.36 |
Platelet count nadir | 0.41 | 0.03 | 0.003 | 0.15 | 0.003 | 0.01 |
Albumin nadir | 0.14 | 0.22 | 0.99 | 0.004 | 0.08 | 0.24 |
Treatment with corticosteroids | 0.2 | 0.04 | 0.03 | 0.27 | 0.15 | > 0.99 |
Treatment with biologicals | 0.04 | > 0.99 | > 0.99 | 0.02 | 0.05 | > 0.99 |
Phase 1 (n = 32) | Phase 2 (n = 25) | P | ||||
Peak ferritin, mg/l (median, IQR) | 370 (249–629) | 1134 (409–1806) | 0.001 (U = 195.5) | |||
Liver enzyme abnormalities (n, %) | 11 (34) | 17 (68) | 0.02 | |||
Peak D-dimer, mg/l (median, IQR) | 2.01 (1.27–3.34) | 4.81 (2.24–5.37) | 0.004 (U = 155.0) | |||
Peak NT-proBNP, ng/l (median, IQR) | 3213 (1216–8483) | 12,217 (3013–27,161) | 0.02 (U = 121.0) | |||
Hypoalbuminemia (n, %) | 25 (81)* | 24 (100)* | 0.03 | |||
Albumin nadir, g/l (median, IQR) | 24 (20–25) | 19 (18–22) | 0.005 (U = 208.5) | |||
Thrombocytopenia (n, %) | 11 (34) | 18 (72) | 0.007 | |||
Platelet counts nadir, x10E9/l (median, IQR) | 215 (133–316) | 127 (104–155) | 0.003 (U = 218.5) | |||
Treatment with corticosteroids (n, %) | 21 (66) | 23 (92) | 0.03 | |||
Non-invasive/mechanical ventilation (n, %) | 0 | 4 (16) | 0.03 |